Coronary Artery Disease
冠状动脉疾病
Make confident diagnostic decisions on coronary artery diseases – fast
快速对冠状动脉疾病做出自信的诊断决定
Be the pulse of connected cardiovascular care and register to get the full experience on our webinar series. Take the chance to join our upcoming live webinars and watch all the recordings on demand.
成为心血管互联护理的脉搏，并注册我们的网络研讨会系列以获得完整的体验。抓住机会加入我们即将到来的现场网络研讨会，并按需观看所有录音。
Discover the benefits of our coronary artery disease patient pathway
发现我们的冠状动脉疾病患者途径的好处
Coronary artery disease (CAD) is the number one cause of death globally, and numbers are rising.1 Healthcare providers need holistic solutions to help them improve diagnostic accuracy, enable effective risk stratification and triage, and support image-guided minimally invasive therapies. Siemens Healthineers has a comprehensive array of multimodality technologies, cardiac biomarkers, a connected digital strategy, and the market foresight to bring cardiology into the future. The unique strengths of our holistic coronary artery disease portfolio help care providers make confident diagnostic decisions on coronary artery disease and get patients on the right pathway – fast. Our clear roadmap is designed to transform care delivery for patients with coronary artery disease.
冠状动脉疾病(CAD)是全球第一大死亡原因，而且这个数字还在上升医疗保健提供商需要整体解决方案来帮助他们提高诊断准确性，实现有效的风险分层和分诊，并支持图像引导的微创治疗。西门子Healthineers拥有全面的多模态技术、心脏生物标志物、互联数字战略，以及将心脏病学带入未来的市场远见。我们的整体冠状动脉疾病组合的独特优势有助于护理提供者对冠状动脉疾病做出自信的诊断决策，并使患者快速走上正确的道路。我们明确的路线图旨在改变冠状动脉疾病患者的护理服务。
Bad news or lucky finding?坏消息还是幸运发现?
Frank, a 50-year-old athletic man, went for a cardio checkup at the request of a friend. Watch his story and learn how his friend saved him from suffering a heart attack.
弗兰克，一个50岁的运动员，在朋友的要求下去做心脏检查。观看他的故事，了解他的朋友如何将他从心脏病发作中拯救出来。
Experience our webinar series for coronary artery disease
体验我们的冠状动脉疾病系列网络研讨会
Tap into the potential
Tap into the potential of multimodality excellence in coronary artery disease
挖掘冠状动脉疾病多模态卓越治疗的潜力
Proven non-invasive testing in risk stratification can prevent unnecessary invasive procedures in coronary artery disease. We are optimizing the patient pathway with a unique portfolio of multimodality imaging and therapy solutions. Our innovations at the point of care and in robotics expand the opportunities improve precision along the patient pathway. Our technologies and digital competence help strengthen interdisciplinary teams for faster care management decisions that can lead to improved clinical outcomes.
经证实的非侵入性风险分层检测可以预防冠状动脉疾病不必要的侵入性手术。我们通过独特的多模态成像和治疗解决方案组合优化患者路径。我们在护理点和机器人技术方面的创新扩大了机会，提高了患者路径的精确度。我们的技术和数字能力有助于加强跨学科团队，以更快地做出护理管理决策，从而改善临床结果。
of diagnostic angiographies show no relevant coronary lesions2
Don't miss a beat
Don’t miss a beat in coronary artery disease with tools designed to speed up and improve workflows
使用旨在加快和改善工作流程的工具，不要错过治疗冠状动脉疾病的机会
Fast, AI-powered decisions can speed up patient triage and diagnosis. With our broad Cardiology portfolio, we provide non-invasive diagnostic solutions with the potential to prevent unnecessary invasive procedures. Our wide range of intuitive applications and modalities can help manage your growing workload. Speed up workflows, reduce costs, and improve patient outcomes in coronary artery disease with optimal image quality, reliability, and connectivity.
人工智能驱动的快速决策可以加快患者的分类和诊断。凭借我们广泛的心脏病学产品组合，我们提供非侵入性诊断解决方案，有可能防止不必要的侵入性手术。我们广泛的直观应用程序和模式可以帮助您管理不断增长的工作量。通过优化图像质量、可靠性和连通性，加快工作流程、降低成本并改善冠状动脉疾病患者的治疗结果。
Step into the future
Step into the future with a clear roadmap for coronary artery disease transformation
带着清晰的冠状动脉疾病转变路线图走向未来
Connecting patient data is the key to making confident diagnostic decisions. As digitalization transforms cardiology, agile partners with a clear strategy and a connected portfolio are essential. Siemens Healthineers has the digital expertise to help you transform to alleviate staff shortages, increase quality, and heighten productivity. Our teamplay digital health platform is one of our connecting elements that opens up possibilities in holistic decision making. Seamless upgrades and lower TCO means you can step into the future with ease on a strong foundation for growth.
连接患者数据是做出可靠诊断决策的关键。随着数字化改变心脏病学，具有明确战略和连接组合的敏捷合作伙伴是必不可少的。西门子Healthineers拥有数字化专业知识，可帮助您进行转型，以缓解人员短缺、提高质量和提高生产力。我们的团队合作数字健康平台是我们的连接元素之一，为整体决策提供了可能性。无缝升级和更低的TCO意味着您可以在坚实的增长基础上轻松迈入未来。
of patients want personalized communication helping to manage their disease4
teamplay myCare Companion – Remote care management solutions
myCare伙伴-远程护理管理解决方案
Chronic diseases place a large economic burden on societies. Find out how care providers can easily set up their own programs to better manage large patient populations with teamplay myCare Companion.
慢性病给社会带来巨大的经济负担。了解护理提供者如何轻松地建立自己的计划，以更好地管理myCare Companion团队合作的大量患者。
Value Partnerships | Cardiology
重视合作伙伴|心脏病学
Achieving operational excellence in cardiac care
We can offer enduring, performance-oriented partnerships. Our all-in-one solution supports your entire cardiovascular care department - beyond technology provision - towards best-in-class operational excellence. Our Value Partnerships help you increase enterprise-wide value in order to meet both your immediate and your future goals.
实现心脏护理的卓越操作
我们可以提供持久的、以业绩为导向的合作伙伴关系。我们的一体化解决方案支持您的整个心血管护理部门-超越技术提供-实现一流的卓越运营。我们的价值合作伙伴关系帮助您提高整个企业的价值，以实现您当前和未来的目标。
Customer Success Story: Hospital do Espírito Santo de Évora, Portugal
Hospital Espírito Santo de Évora (HESE) is the primary inpatient care facility in Alentejo, the largest region in the country. Alentejo is very rural, and the population consists largely of elderly individuals. The main cause of death is cardiovascular disease. To better respond to the needs of the local population, HESE partnered with Siemens Healthineers to implement two integrated solutions:
客户成功案例:医院做Espírito Santo de Évora，葡萄牙
Espírito Santo de Évora医院(HESE)是该国最大地区阿连特茹的主要住院护理机构。阿连特茹非常偏远，人口主要由老年人组成。死亡的主要原因是心血管疾病。为了更好地满足当地人群的需求，HESE与西门子医疗合作，实施了两个集成解决方案:
1. The modernization of the cardiac catheterization laboratory (cath lab), as well as the addition of a new cath lab.
2. The development of a telehealth program for remote care management to serve patients with cardio vascular conditions before and after interventions.
1. 现代化的心导管实验室(导管室)，以及增加了一个新的导管室。
2. 开发用于远程护理管理的远程保健计划，为干预前后患有心血管疾病的患者提供服务。
阅读全文
Clinical experiences临床 经验
"CT angiography, CTA gives us this certainty of what’s going on. So that is the great advantage that I’m not guessing and looking at probabilities, but I’m really sure what’s going on. And accordingly can give my advice to the patients how they should be treated."
Medical Director, CCB Frankfurt, Germany
News & Stories
Conferences
EuroPCR 2022
17-20 May 2022, Paris
HIMSS Europe
14 - 16 June, 2022, Helsinki
Discover our education material
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.
1) https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
2) https://www.tctmd.com/news/cardiac-mri-and-spect-reduce-unnecessary-angiograms-vs-guideline-directed-care-suspected-cad
3) See, for example, Zimmermann FM, Omerovic E, Fournier S, et al. Fractional flow reserveguided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data. Eur Heart J 2019; 40(2): 180–86.
4) https://www.healthpopuli.com/2019/02/07/the-expectation-gap-between-what-patients-want-vs-what-they-get/